Professor Jim Smith, now Professor of Pharmacy Practice and Policy at the University of Sunderland, will also highlight several other controversial issues that surround the pharmaceutical sector and its practice.
Prof Smith was appointed England’s Chief Pharmaceutical Officer in 2001 and was in charge of implementing the Government's "Vision for Pharmacy" programme.
In his inaugural lecture at the university on Thursday, Prof Smith will explain why millions are being wasted on prescribed drugs that people are not using.
He will argue that of the £11bn spent each year on prescription drugs a substantial proportion of that is wasted through non-compliance, often impairing the health of those people for who the drugs are meant.
Prof Smith says: “There is good evidence that people accumulate large quantities of drugs but don’t use them, wasting money that the NHS can ill afford.
“There is also evidence that non-compliance it is linked to socio economic status – which has connotations for places like Sunderland – widening the health gap.
“Every Primary Care Trust is struggling with the costs of providing health care. However, so many of these medicines are not being taken, which is leading to further health problems
“There is evidence for example that some heart attack victims, who may be prescribed up to four drugs, do not take them properly and puts them at greater risk of a second heart attack.
“It’s a major problem. Fifteen per cent of NHS spending is on prescribed drugs.
“Many people, ultimately almost all of us, rely on medicines for their wellbeing. They can be life-enhancing and, for many people, lifesaving.
“Modern medicines are the product of an unprecedented scientific, clinical and industrial enterprise in which Britain is a world leader. They are contributing significantly to the increases in life expectancy and quality of life now being seen in this country. But our attitudes to medicines are ambivalent.
“We distrust the corporations that have, so successfully, developed new medicines. Governments laud the economic success of the industry but are sometimes reluctant to meet the cost of new drugs.
“The public, influenced at times by the news media, call for government bans in response to ‘drug scares’ but, paradoxically, also press for new drugs to be introduced across the NHS before clinical and economic evaluations are complete.”
Prof Smith’s lecture will explore these issues and argue for a mature and informed approach to the medicines we take.
He has worked as a community, industrial and hospital pharmacist and has held senior posts in health authorities in the North of England and in Central Government.
He has held consultancies with a number of pharmaceutical companies and with the World Health Organisation. In 2006 he was admitted as a fellow of the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom.
Tony Kerr | alfa
Clock stars: Astrocytes keep time for brain, behavior
27.03.2017 | Washington University in St. Louis
Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
27.03.2017 | Health and Medicine
27.03.2017 | Life Sciences
27.03.2017 | Earth Sciences